Artwork

Content provided by Project Medtech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Project Medtech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 193 | Kristen Mittal and Mridul Mittal at Mittal Consulting | Regulatory Consultant vs. Regulatory Strategist

46:23
 
Share
 

Manage episode 438956347 series 2788129
Content provided by Project Medtech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Project Medtech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode, Kristen Mittal and Mridul Mittal at Mittal Consulting and Duane Mancini discuss their unique backgrounds in medtech, why they started Mittal Consulting, what medtech companies should expect from a regulatory strategy report, breakthrough designation, 513(g) vs. pre-submission meetings, common pitfalls, their advice for entrepreneurs, and so much more.

⁠Kristen Mittal LinkedIn⁠

⁠Mridul Mittal LinkedIn⁠

⁠Mittal Consulting LinkedIn⁠

⁠Mittal Consulting Website ⁠

⁠Duane Mancini LinkedIn⁠

⁠Project Medtech LinkedIn⁠

⁠Project Medtech Website

  continue reading

278 episodes

Artwork
iconShare
 
Manage episode 438956347 series 2788129
Content provided by Project Medtech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Project Medtech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode, Kristen Mittal and Mridul Mittal at Mittal Consulting and Duane Mancini discuss their unique backgrounds in medtech, why they started Mittal Consulting, what medtech companies should expect from a regulatory strategy report, breakthrough designation, 513(g) vs. pre-submission meetings, common pitfalls, their advice for entrepreneurs, and so much more.

⁠Kristen Mittal LinkedIn⁠

⁠Mridul Mittal LinkedIn⁠

⁠Mittal Consulting LinkedIn⁠

⁠Mittal Consulting Website ⁠

⁠Duane Mancini LinkedIn⁠

⁠Project Medtech LinkedIn⁠

⁠Project Medtech Website

  continue reading

278 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play